Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting IP3R-mediated Ca2+ homeostasis in adipocytes as strategy against metabolic disease

Jan. 17, 2022

New 3,5-diaryl-substituted pyrazoles inhibit prostate cancer cell growth

Jan. 17, 2022

Viral replication inhibitors patented by Gilead

Jan. 17, 2022

New glucocorticoid receptor antagonists discovered at Corcept Therapeutics

Jan. 17, 2022

Celgene presents new cereblon-binding PROTACs

Jan. 17, 2022

New GLP-1 receptor agonists identified at Guangzhou Henovcom Bioscience

Jan. 17, 2022

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

Jan. 17, 2022

Machine learning approach speeds resistance identification

Jan. 17, 2022

Novel ER modulator daidzein analogues confer antitumoral effect in prostate cancer

Jan. 17, 2022

Study brings clarity on how MS starts, although not yet why

Jan. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...